Novartis lung cancer drug Zykadia® gains EU approval, providing new therapy for certain patients with ALK+ NSCLC
5/12/2015

Novartis has announced that the European Commission has approved Zykadia® (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer...

Parents' decision-making in HPV vaccination of daughters unriddled
5/12/2015

Human Papillomavirus (HPV) is a leading cause of sexually transmitted diseases, with more than 70% of sexually active people getting the virus at least once in their lifetimes.

Impact of post-treatment surveillance in head & neck squamous cell cancer
5/12/2015

Compliance with post-treatment surveillance, income level and the travel distance for follow-up care had effects on survival in patients with head and neck squamous cell cancer (HNSCC), according...

UK HR professionals give backing to universal cancer checks for employees
5/12/2015

All employers should be providing annual cancer screening for staff, according to a new survey of HR professionals on the impact of the cancer 'epidemic' on the workplace.

Doctors failing to spot childhood eye cancer in majority of cases
5/12/2015

A children's cancer charity is launching a bold new awareness campaign for World Retinoblastoma Awareness Week (10-16 May) as new figures show less than half of children with eye cancer receive the...

Moffitt researchers work to determine why some prostate cancer patients experience more hot flashes
5/12/2015

New study shows men who are younger or have a lower body mass index are more prone to experience hot flashes during androgen deprivation therapyAndrogen deprivation therapy (ADT) is a common...

UM biologist advances cancer research with new data analysis techniques
5/12/2015

Patience and persistence are beginning to pay off for University of Montana Professor Mark Grimes, whose research about the behavior of cell proteins in childhood cancer recently was published by...

Tracking defects caused by brain tumor mutation yields insight to advance targeted therapy
5/12/2015

St. Jude Children's Research Hospital scientists show that mutations in the DDX3X gene lead to different molecular defects; findings will aid efforts to develop more individualized therapy of...

New combination treatment strategy to 'checkmate' glioblastoma
5/12/2015

Three different classes of anti-cancer drugs work synergistically against brain tumorsThis image showsn normal cell dividing (left) and stressed cancer cell dividing (right).

Will Mexico's aging population see cancer care as a priority?
5/12/2015

For this dynamic middle-income country, it's time to think about cancer futuresMexico is undergoing a transformation: ranked as the second largest economy in Latin America, it's an increasingly...